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Abstract. In this work we study the inflammatory process resulting in the development of
atherosclerosis. We develop a one- and two-dimensional models based on reaction-diffusion
systems to describe the set up of a chronic inflammatory response in the intima of an
artery vessel wall. The concentration of the oxidized low density lipoproteins (ox-LDL) in
the intima is the critical parameter of the model. Low ox-LDL concentrations do not lead
to a chronic inflammatory reaction. Intermediate ox-LDL concentrations correspond to a
bistable system and can lead to a travelling wave propagation corresponding to a chronic
inflammatory reaction. In this case the disease development depends on the initial
condition. If the concentration of monocytes in the intima is sufficiently high, which can be
caused by an inflammation related to other factors, then the development of atherosclerosis
can start. Otherwise, the system returns to the stable disease free equilibrium. High
ox-LDL concentrations correspond to a monostable system and even a small perturbation
of the non inflammatory case leads to a travelling wave propagation which corresponds to a
chronic inflammatory response.
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1 Atherogenesis mechanism
During last decades, several theories about pathogenesis of the atherosclerosis have been
developed. None of these theories can explain the whole process because of the big number
1Corresponding author. Email: nader@math.univ-lyon.fr
126
Article available at http://www.mmnp-journal.org or http://dx.doi.org/10.1051/mmnp:2008022
N. El Khatib et al. Atherosclerosis initiation as an inflammatory process
of risk factors that contribute to this process [1]. In spite of these multiple theories, the
concept of ”atherosclerosis as an inflammatory disease” is now well accepted (see [2] and
the references therein).
High plasma concentration of low density lipoprotein (LDL) cholesterol is one of the
principal risk factors for atherosclerosis. Its mechanism can be sketched as follows [2, 3]:
the process of atherosclerosis begins when LDLs penetrate into the intima of the arterial
wall where they are oxidized. Oxidized LDL (ox-LDL) in the intima is considered by the
immune system as a dangerous substance, hence an immune response is launched:
chemoattractants (which mediate the adhesion of the monocytes to the endothelium and
the penetration of the monocytes through the endothelium) are released and endothelial
cells are activated so that monocytes circulating in the blood adhere to the endothelium
and then they penetrate to the arterial intima. Once in the intima, these monocytes are
converted into macrophages.
The macrophages phagocytose the ox-LDL but this eventually transform them into foam
cells (lipid-ladden cells) which in turn have to be removed by the immune system. In the
same time they set up a chronic inflammatory reaction (auto-amplification phenomenon):
they secrete pro-inflammatory cytokines (TNF-α, IL-1) which increase endothelial cells
activation, promote the recruitment of new monocytes and support the production of new
pro-inflammatory cytokines.
This auto-amplification phenomenon is compensated by an anti-inflammatory phenomenon
mediated by the anti-inflammatory cytokines (IL-10) which inhibit the production of
pro-inflammatory cytokines (biochemical anti-inflammation). Next, the inflammation
process involves the proliferation and the migration of smooth muscle cells to create a
fibrous cap over the lipid deposit which isolates this deposit center from the blood flow
(mechanical anti-inflammation).
This mechanical inhibition of the inflammation may become a part of the disease process.
Indeed the fibrous cap changes the geometry of the vasculature and modifies the blood
flow. The interaction between the flow and the cap may lead to a thrombus, or to the
degradation and rupture of the plaque liberating dangerous solid parts in the flow [4, 5].
In this study we do not address the fluid-structure interaction between the blood flow and
the plaque, and only consider the set up of the chronic inflammatory reaction with its
biochemical and mechanical inhibitions. We provide a simplified model of the reactions
arising in the arterial intima. This model allows us to give the following biological
interpretation: at low LDL concentrations the auto-amplification phenomenon does not set
up and no chronic inflammatory reaction occurs. At intermediate concentrations a
perturbation of the non inflammatory state may lead to the chronic inflammation, but it
has to overcome a threshold for that. Otherwise the system returns to the disease free
state. At large LDL concentrations, even a small perturbation of the non inflammatory
state leads to the chronic inflammatory reaction.
In Section 2 we introduce and study analytically and numerically a one-dimensional model
of atherosclerosis development. In Section 3 we consider a two-dimensional model. The
latter will allow us to describe in more detail the recruitment of monocytes from the blood
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flow. Numerical simulations show that we recover the results of the 1D model when the
domain is thin enough.
2 One-dimensional model
We consider here a reaction-diffusion system of equations on an interval representing the
arterial intima: 
∂M
∂t
= d1
∂2M
∂x2
+ f1(A)− λ1M,
∂A
∂t
= d2
∂2A
∂x2
+ f2(A)M − λ2A,
(2.1)
for x ∈ [0, L]. Here M is the density of immune cells (monocytes, macrophages) and A is
the density of the cytokines secreted by the immune cells. The function f1(A) models the
recruitment of the immune cells from the blood flow, promoted by the inflammatory
cytokines:
f1(A) =
α1 + β1A
1 + A/τ1
,
where α1 = f1(0) corresponds to the beginning of the inflammation, that is the recruitment
of monocytes due to the presence of ox-LDL, promoted by endothelial adhesion molecules,
chemoattractants and growth factors.
The factor β1 represents the auto-amplification of the recruitment of monocytes due to the
inflammatory cytokines secreted by the monocytes themselves. The factor 1 + A/τ1
represents the mechanical saturation of the recruitment of M i.e. the effect of the fibrous
cap created by smooth muscle cells, with τ1 being the characteristic time for the fibrous
cap formation. Although this phenomenon is quite complex and involves proliferation and
migration of smooth muscle cells, we only describe it as a saturation factor in this simple
model.
The term f2(A)M models the cytokines production rate, with
f2(A) =
α2A
1 + A/τ2
,
where α2A represents the secretion of pro-inflammatory cytokines promoted by the
pro-inflammatory cytokines themselves and 1 + A/τ2 represents the inhibition of the
pro-inflammatory cytokines secretion mediated by the anti-inflammatory cytokines, with τ2
being the necessary time for this inhibition to act.
The terms −λ1M and −λ2A represent the degradation of the immune cells M and the
cytokines A respectively, d1
∂2M
∂x2
and d2
∂2A
∂x2
describe their diffusion (or cell displacement)
in the intima.
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All the parameters of the model, α1, β1, τ1, α2, τ2, λ1, λ2, d1 and d2 are assumed to be
non-negative. Besides, for f1 to be an increasing function of A, we impose the condition
τ1 >
α1
β1
. (2.2)
2.1 Kinetic system
In order to determine the conditions for the set up of the inflammatory reaction, we first
study only the reaction part of system (2.1), that is we consider the kinetic system of
equations 
dM
dt
= f1(A)− λ1M,
dA
dt
= f2(A)M − λ2A.
(2.3)
2.1.1 Equilibrium points
The isoclines of system (2.1) are defined by the equations{
f1(A)− λ1M = 0,
f2(A)M − λ2A = 0,
or introducing the notations F1 and F2,
M = F1(A) ≡ f1(A)
λ1
,
M = F2(A) ≡ λ2A
f2(A)
.
The number of equilibrium points depends on the parameters. We present here different
cases and refer to the appendix A for the detailed computations:
The point E0 =
(
0,
α1
λ1
)
is an equilibrium point for any values of the parameters. The
existence of other equilibrium points is determined by the equation F1(A) = F2(A):
λ2
α2τ1τ2
A2 +
(
λ2
α2
(
1
τ1
+
1
τ2
)
− β1
λ1
)
A+
λ2
α2
− α1
λ1
= 0. (2.4)
• If λ2
α2
<
α1
λ1
, there is only one positive solution of equation (2.4), denoted by Ar. We
denote by Er = (Ar,Mr) the corresponding equilibrium. This case is represented in
figure 1.
• Let α1
λ1
<
λ2
α2
<
β1τ1
λ1
.
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• If 0 < λ2
α2τ2
<
(√
β1
λ1
− α1
τ1λ1
−
√
λ2
α2τ1
− α1
τ1λ1
)2
, then there exist two positive
solutions of equation (2.4), denoted by Al and Ar, where Al < Ar. The corresponding
equilibrium points are denoted by El = (Al,Ml) and Er = (Ar,Mr). This case is
represented in figure 2.
• If
(√
β1
λ1
− α1
τ1λ1
−
√
λ2
α2τ1
− α1
τ1λ1
)2
<
λ2
α2τ2
, then there is no positive solution
to equation (2.4). This case is represented in figure 3.
• If β1τ1
λ1
<
λ2
α2
there is no positive solution to equation (2.4).
2.1.2 Stability analysis
• The stability of E0 is determined by the Jacobian matrix
JE0 =
 −λ1 f
′
1(0)
0 α2
α1
λ1
− λ2

whose eigenvalues are µ1 = −λ1 < 0 and µ2 = α2α1
λ1
− λ2. Denoting E1 =
(
0,
λ2
α2
)
,
we observe that if E0 is situated below E1 then E0 is a stable equilibrium, otherwise
it is unstable.
• The stability of El is determined by
Jl =

−λ1 f ′1(Al)
f2(Al) f
′
2(Al)
λ2Al
f2(Al)
− λ2

whose determinant is det(Jl) = λ1λ2 − λ1f ′2(Al)
λ2Al
f2(Al)
− f2(Al)f ′1(Al). Since F1 is
concave and F2 is a straight line, it holds F
′
1(Al) > F
′
2(Al), that is
f ′1(Al)
λ1
>
λ2f2(Al)− λ2Alf ′2(Al)
f 22 (Al)
,
which implies det(Jl) < 0. Hence El is unstable.
• The stability of Er is determined by
Jr =

−λ1 f ′1(Ar)
f2(Ar) f
′
2(Ar)
λ2Ar
f2(Ar)
− λ2
 .
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The condition F ′1(Ar) < F
′
2(Ar) leads to det(Jr) > 0.
In order to determine the sign of the eigenvalues, we study the trace of Jr:
tr(Jr) = −λ1 − λ2 + f ′2(Ar)
λ2Ar
f2(Ar)
.
The condition F ′1(Ar) < F
′
2(Ar) leads to
f ′2(Ar)
λ2Ar
f2(Ar)
< λ2 − f
′
1(Ar)f2(Ar)
λ1
which implies tr(Jr) < 0. Therefore Er is a stable equilibrium.
Figure 1: The case λ2
α2
< α1
λ1
: two equilibrium points, E0 is unstable and Er is stable (the
monostable case).
2.1.3 Biological interpretation
The equilibrium points of the kinetic system admit the following biological interpretation:
E0 (no cytokines and low concentration of immune cells) corresponds to the non
inflammatory state, whereas Er (large concentrations of cytokines and immune cells)
corresponds to the inflammatory state; E0 can be stable or unstable, and Er is always
stable when it exists.
The intermediate equilibrium El is always unstable when it exists. It represent a threshold
the system has to overcome in order to move from the non inflammatory state E0 to the
inflammatory one Er.
The critical values for the existence and stability of these equilibria were given in terms of
the parameters
λ2
α2
and
λ2
α2τ2
in the last two subsections. The biological interpretation can
be more conveniently given in terms of the parameter α1 which corresponds to the ox-LDL
concentration. But the computation of the critical values between the different cases in
terms of α1 would be more difficult:
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Figure 2: The case α1
λ1
< λ2
α2
< β1τ1
λ1
and 0 < λ2
α2τ2
<
(√
β1
λ1
− α1
τ1λ1
−
√
λ2
α2τ1
− α1
τ1λ1
)2
: three
equilibrium points, E0 and Er are stable and El is unstable (bistable case).
Figure 3: The case α1
λ1
< λ2
α2
< β1τ1
λ1
and λ2
α2τ2
>
(√
β1
λ1
− α1
τ1λ1
−
√
λ2
α2τ1
− α1
τ1λ1
)2
: only one
equilibrium point, E0 which is stable.
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• if α1 is small (low ox-LDL concentration) E0 is the only equilibrium and it is stable.
No chronic inflammatory reaction can set up. This case is represented in figure 3.
• if α1 is intermediate, there are three equilibrium points: E0 and Er are stable and El
is unstable. This case is called bistable case and is represented in figure 2. The
system will reach Er if the initial conditions are large enough and E0 otherwise.
Hence a chronic inflammatory reaction may set up, but for that it has to overcome a
threshold.
• if α1 is large, there are two equilibrium points: E0 is unstable and Er is stable. This
case is called monostable case and is represented in figure 1. Even a small
perturbation of E0 will lead to Er. Hence even a small perturbation of the non
inflammatory state leads to the set up of a chronic inflammatory reaction.
2.2 Existence and numerical simulations of travelling waves
We now investigate the conditions for the propagation of the chronic inflammatory
reaction. To this aim we consider the reaction and diffusion phenomena and we turn back
to system (2.1). For the theoretical study the space domain will be the entire real line
]−∞,+∞[ and for the numerical simulations it will be the segment [0, L]. A travelling
wave solution of system (2.1) is a particular solution representing a front with constant
velocity connecting two equilibria of system (2.3), that is a solution of the form(
A(t, x)
M(t, x)
)
= W (x− ct) (2.5)
where the constant c is a speed of the wave and
lim
x→±∞
W (x) = W± (2.6)
with W+ and W− being two equilibria of system (2.3).
Recall that a reaction-diffusion system is called globally monotone if the off-diagonal
elements of its Jacobian matrix are positive.
Proposition 2.2.1. System (2.1) is globally monotone.
Proof. Denoting U(A,M) =
(
U1
U2
)
(A,M) =
(
f1(A)− λ1M
f2(A)M − λ2A
)
, we have
∂U1
∂A
(A,M) = f ′1(A) > 0,
∂U2
∂M
(A,M) = f2(A) > 0.
The monotony of the system ensures the existence of travelling wave solutions in the
bistable case and in the monostable case (see figures 1 and 2 and Section 2.1.3). The
uniqueness of waves holds in the bistable case but not in the monostable one (see e.g. [6],
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Theorem 1.1 and Theorem 1.2, Chapter 3). For system (2.1), this yields the following two
results:
Theorem 2.2.2. In the bistable case, there exists a unique travelling wave solution
connecting the non inflammatory state E0 and the inflammatory state Er, i.e. a constant c
and a vector valued function W (x− ct), solution of system (2.1) on the real line
]−∞,+∞[ and satisfying equation (2.6) with W− = Er and W+ = E0.
Theorem 2.2.3. In the monostable case, there exists a constant c? such that
∀c ∈ [c?,+∞[, there exists a travelling wave solution of velocity c connecting the non
inflammatory state E0 and the inflammatory state Er, i.e. a vector valued function
W (x− ct), solution of system (2.1) on the real line ]−∞,+∞[ and satisfying equation
(2.6) with W− = Er and W+ = E0.
2.2.1 Numerical simulations
We illustrate the previous results by numerical simulations. System (2.1) on the 1D
interval [0, L] with the homogeneous Neumann boundary conditions is solved using finite
differences. The diffusion term is discretized implicitly and the reaction term explicitly.
We first simulate the bistable case. The values of the parameters are L = 1, α1 = 2, β1 = 8,
τ1 = 1, λ1 = 1, d1 = 1, α2 = 7, τ2 = 13/2, λ2 = 26 and d2 = 1. The system exhibits a
threshold effect: a small perturbation of E0 does not lead to the propagation of a chronic
inflammation (figure 4) whereas a large perturbation of E0 does (figure 5).
Figure 4: Threshold effect in the bistable case. A small perturbation of the non inflammatory
state does not lead to the propagation of a chronic inflammatory reaction.
We then consider the monostable case. The values of the parameters are L = 1, α1 = 2,
β1 = 8, τ1 = 1, λ1 = 1, d1 = 1, α2 = 1, τ2 = 42/43, λ2 = 1 and d2 = 1. There is no
threshold effect any more. Even small perturbation of E0 leads to the propagation of a
chronic inflammation.
Since the monotonicity of the system ensures the existence of travelling waves, the
conclusions about the onset of a chronic inflammatory reaction is valid also for its
propagation: for large ox-LDL concentration, even a small perturbation of the non
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Figure 5: Wave propagation in the bistable case. A large perturbation of the non inflamma-
tory state leads to the propagation of a chronic inflammatory reaction.
Figure 6: Monostable case. Even a small perturbation of the non inflammatory state leads
to the propagation of a chronic inflammatory reaction.
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inflammatory state leads to the development and propagation of the chronic inflammation,
whereas for intermediate ox-LDL concentrations it occurs only for large perturbations.
3 Two-dimensional model
3.1 Formulation of the model
The inflammatory reaction takes place in the arterial intima but it involves the recruitment
of monocytes from the blood flow. Hence in a more detailed description, the function f1(A)
describing this recruitment should appear as a boundary condition for a model of the
intima, and not as a source term.
This is the reason why we developed a two-dimensional model of the intima. The domain is
the rectangle Ωε = [0, L]× [0, ε]. The boundary between the intima and the blood flow is
assumed to be the upper horizontal side (figure 7). The length of the vertical sides is ε. We
expect to recover the qualitative results of the 1D-model as ε tends to 0 (thin domain
limit). Indeed the intima is a thin part of the arterial wall accounting for less than 10% of
the total wall thickness. The intima thickness is then much smaller than the typical
dimensions of the atherosclerotic lesion. The incoming flux of monocytes decreases
proportionally to the width of the domain. Otherwise their concentration in the intima will
grow to infinity. This implies the presence of the small parameter in the boundary
condition.
We consider the system of equations
∂Mε
∂t
= d1∆Mε − λ1Mε,
∂Aε
∂t
= d2∆Aε + f2(Aε)Mε − λ2Aε,
(3.7)
in Ωε. For the immune cells concentration Mε we consider no flux (homogeneous
Neumann) boundary conditions on the vertical and lower horizontal sides, and a non-zero
flux depending on Aε on the upper horizontal side:
∂Mε
∂x
(0, y) =
∂Mε
∂x
(L, y) = 0 for y ∈ [0, ε], ∂Mε
∂y
(x, 0) = 0 for x ∈ [0, L], and
∂Mε
∂y
(x, ε) =
f1(A)
d1
² for x ∈ [0, L]. (3.8)
For the cytokines concentration Aε, we impose homogeneous Neumann boundary
conditions everywhere.
The proof of the convergence towards the 1D-model in the thin domain limit will be
studied in the subsequent work. Formal asymptotic expansion (see appendix B) shows that
the prescribed flux for Mε has to be scaled according to equation (3.8).
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Figure 7: Geometry and boundary conditions of the two-dimensional model.
3.2 Numerical simulations
The simulations in the two-dimensional case are performed by using COMSOL
Multi-physics (COMSOL c©). With the same values of the coefficients as for the
mono-dimensional model we obtain the same qualitative behavior, provided the domain is
thin enough.
We first take the parameters from the bistable case of the 1D-model: L = 1, α1 = 2,
β1 = 8, τ1 = 1, λ1 = 1, d1 = 10
−3, α2 = 7, τ2 = 13/2, λ2 = 26 and d2 = 10−3. For ε small
enough (ε = 10−3 here) the solution Mε(x, y) weakly depends on y and exhibits the same
thresholds effect as for the 1D-model. Indeed a small perturbation of the non inflammatory
state does not lead to the propagation of the inflammation (not shown), whereas a large
enough perturbation does (see figure 3.2).
Figure 8: Parameters from the bistable case of the 1D-model. The solution weakly depends
on y (the y-direction is stretched on the figure). A large enough perturbation of the non in-
flammatory state leads to the propagation of a chronic inflammation. Top: initial condition.
Bottom: wave propagation.
We then take the parameters from the monostable case of the 1D-model: L = 1, α1 = 2,
β1 = 8, τ1 = 1, λ1 = 1, d1 = 10
−3, α2 = 1, τ2 = 42/43, λ2 = 1, d2 = 10−3, and ε = 10−3. As
for the bistable case Mε(x, y) weakly depends on the y variable, and we recover the
behavior of the 1D-model: even a small perturbation of the non inflammatory state leads
137
N. El Khatib et al. Atherosclerosis initiation as an inflammatory process
to the propagation of a chronic inflammatory reaction (figure 3.2).
Figure 9: Parameters from the monostable case of the 1D-model. The solution weakly
depends on y (the y-direction is stretched on the figure). Even a small perturbation of the
non inflammatory state leads to the propagation of a chronic inflammation. Top: initial
condition. Bottom: wave propagation.
4 Appendix A
In order to determine the solutions of equation (2.4) it is convenient to rename the
cœfficients of F2: F2(A) = α + βA where α =
λ2
α2
and β =
λ2
α2τ2
. Then equation (2.4)
rewrites as
β
τ1
A2 +
(
α
τ1
+ β − β1
λ1
)
A+ α− α1
λ1
= 0. (4.9)
This is a second order polynomial with respect to A whose discriminant is
∆A = β
2 + 2
(
2
α1
λ1τ1
− β1
λ1
− α
τ1
)
β +
(
α
τ1
− β1
λ1
)2
.
It is also convenient to introduce p =
(
α− α1
λ1
)
τ1
β
and s =
(
β1
λ1
− α
τ1
− β
)
τ1
β
,
respectively the product and the sum of the roots of equation (4.9).
We discuss the number of solutions to equation (4.9) with respect to the two parameters α
and β.
We distinguish three cases:
• If α < α1
λ1
then p < 0 and there is only one positive solution of equation (2.4),
denoted by Ar.
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• Assume
α1
λ1
< α <
β1τ1
λ1
. (4.10)
Then p > 0. We study the sign of ∆A by considering it as a second order polynomial
with respect to the slope β. Its reduced discriminant is
∆′β = 4
(
α1
λ1τ1
− β1
λ1
)(
α1
λ1τ1
− α
τ1
)
.
and it is positive under assumption 4.10 thanks to equation (2.2). The roots the
equation ∆A = 0 are
β− =
(√
β1
λ1
− α1
τ1λ1
−
√
α
τ1
− α1
τ1λ1
)2
and
β+ =
(√
β1
λ1
− α1
τ1λ1
+
√
α
τ1
− α1
τ1λ1
)2
.
Note that under assumption 4.10,
β− <
β1
λ1
− α
τ1
< β+. (4.11)
Hence,
• If 0 < β < β−, then there exist two solutions of equation (4.9). According to
equation (4.11), s is positive, and these two solutions are positive too. We denote
them by Al and Ar, where Al < Ar.
• If β− < β, then there is no positive solution to equation (4.9) (for β− < β < β+,
∆A < 0 and equation (4.9) has no real solution, whereas for β+ < β, ∆A > 0 but
s < 0 and equation (4.9) has two negative solutions).
• If β1τ1
λ1
< α, then s is negative and there is no positive solution to equation (4.9).
5 Appendix B
We formally justify the scaled boundary condition for Mε in equation (3.8). To this aim,
we consider the change of variable z = y/ε, and set M¯(t, x, z) =Mε(t, x, y). The equation
for M¯ is then
∂M¯
∂t
= d1
∂2M¯
∂x2
+
d1
ε2
∂2M¯
∂z2
M − λ1M¯, (5.12)
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on the stretched domain Ω = [0, L]× [0, 1], with homogeneous Neumann boundary
conditions on the vertical and lower horizontal sides and with
∂M¯
∂z
(x, 1) =
f1(A)
d1
²2 for x ∈ [0, L], (5.13)
on the upper horizontal side.
We consider the formal expansion of M¯
M¯(t, x, z) =M0(t, x, z) + εM1(t, x, z) + ε
2M2(t, x, z) + . . . (5.14)
and insert it in equation (5.12) and boundary condition (5.13).
Collecting the cœfficients of ε−2 in equation (5.12) yields:
∂2M0
∂z2
= 0
on Ω with the boundary conditions
∂M0
∂z
(x, 0) =
∂M0
∂z
(x, 1) = 0. This shows that M0 is
independent of z.
Collecting the cœfficients of ε0 in equation (5.12) yields:
∂M0
∂t
= d1
∂2M0
∂x2
+ d1
∂2M2
∂z2
− λ1M0
Since M0 does not depend on z, integrating the latter equation with respect to z between 0
and 1 gives:
∂M0
∂t
= d1
∂2M0
∂x2
+ d1
∂M2
∂z
(x, 1)− ∂M2
∂z
(x, 0)− λ1M0.
Now collecting the cœfficients of ε2 in equation (5.13) gives
∂M2
∂z
(x, 1) =
f1(A)
d1
and since
∂M2
∂z
(x, 0) = 0 (homogeneous Neumann conditions on the lower horizontal side), this leads
to the 1D equation:
∂M0
∂t
= d1
∂2M0
∂x2
+ f1(A)− λ1M0.
Hence the solution of the 2D-model tends formally to the solution of the 1D-model when ε
tends to 0.
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